Impact of Continuous Manufacturing Processes on the Viral Safety of Therapeutic Proteins | FDA
Planova™ | Portal for Medical Materials | Asahi Kasei Corporation
Asahi Gold Particle Test System-II
Asahi Kasei Bioprocess' Planova SU-VFC: Realizing Single-Use Technology in Virus Filtration - BioProcess InternationalBioProcess International
Mechanistic insights into flow-dependent virus retention in different nanofilter membranes - ScienceDirect
Minimizing Resources in Developing Commercial Virus Filtration Processes with Planova BioEX - BioProcess InternationalBioProcess International
Filters
Operation and Use of the PLANOVAr Filtration Device
Custom Planova Filter Stands: A Superior Single-Use Solution
Planova BioEX: Leading the Next Generation of Virus Filters - BioProcess InternationalBioProcess International
Planova™ 15N, 20N & 35N Virus Removal Filters | Asahi Kasei Bioprocess
Planova™ 15N, 20N & 35N Virus Removal Filters | Asahi Kasei Bioprocess
Potential Contribution of Nanofiltration to the Virus Safety of Domestic Plasma Components
Planova™ 15N, 20N & 35N Virus Removal Filters | Asahi Kasei Bioprocess
Manufacturing Considerations for Virus Filtration Processes Using Planova BioEX - BioProcess InternationalBioProcess International
Planova™ BioEX Virus Removal Filters | Asahi Kasei Bioprocess
Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China - ScienceDirect
New Challenges in Virus Filtration: Continuous Manufacturing, Use of Virus Filter as an Upstream Barrier
Planova™ 15N, 20N & 35N Virus Removal Filters | Asahi Kasei Bioprocess
Planova™: Virus Removal Filter for Biotherapeutic Drug - Asahi Kasei India
Antiviral filter - Planova™ S20N - Asahi Kasei Medical Co. - hollow-fiber / plasma / laboratory
Launch of Planova™ BioEX Virus Filters for Biopharmaceutical Processing - BioProcess InternationalBioProcess International
